You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百奧賽圖-B(02315.HK)公佈業績:2022年收益5.34億元 同比增長50.6%
格隆匯 03-27 18:23

格隆匯3月27日丨百奧賽圖-B(02315.HK)發佈公吿,截至2022年12月31日止年度,收益為人民幣5.34億元,同比增長50.6%;毛利為人民幣3.92億元,同比增長58.3%。2022年度收益增加主要受集團的臨牀前藥理藥效評估、模式動物銷售及抗體開發的收入增加所推動。

截至2022年12月31日,集團三個服務中心有約550名研發人員從事臨牀前研究服務。大部分研發人員涵蓋藥物開發及臨牀前研究服務。具體而言,集團的研發人員中,約100名負責基因編輯及模式動物銷售,約150名負責臨牀前藥理藥效評估,約230名負責抗體開發及約50名負責臨牀開發。截至2021年及2022年12月31日止年度,集團的研發費用分別為人民幣5.59億元及人民幣6.99億元。截至2022年12月31日止年度,核心產品的研發費用為人民幣1.05億元,約佔同期研發費用的15.0%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account